|

Ianalumab Clinical Trials

2 actively recruiting trials across 2 locations

No change since June 2026

Also known as: VAY736

Pipeline

Phase 3: 2

Top Sponsors

  • Novartis Pharmaceuticals2

Indications

  • Lupus2
  • Lupus Nephritis1
  • Systemic Lupus Erythematosus1

Anniston, Alabama1 trial

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Pinnacle Research Group Llc

Phase 3

Orchard Park, New York1 trial

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Circuit Clinical

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.